Aurinia Closes US$173.1 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares

World News: . []

Aurinia Pharmaceuticals Inc NASDAQAUPH TSXAUP (“Aurinia” or the Company a clinical stage biopharmaceutical company focused on the global immunology market, today announced the closing of its previously announc...

More news and information about Aurinia Pharmaceuticals Inc.

Published By:

Business Wire: 20:05 GMT Monday 20th March 2017

Published: .

Search for other references to "aurinia" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers